72
Transactions
JULY 2014
Santo Holding Deutschland
acquires Astellas’ OTC products portfolio in Germany and Austria
Legal advisor to Santo Holding:
Santo Holding Deutschland acquires Astellas’ OTC products portfolio in Germany and Austria
Japanese pharmaceutical company wants to sell its subsidiary blade. Currently, negotiations are underway with interested parties."Conversation is completely Klinge Pharma to sell," says Gerd Witt, commercial manager of Astellas in Germany.
M&A advisor to Santo Holding:
Astellas sells non-prescription medicines Venostasin, Alfason, Arctuvan, Doctan, Phosphalugel, Vomex and Vertigo Vomex. The top-selling product is Vomex (dimenhydrinate) for nausea and vomiting. The pharmacy sales service with about 20 employees, has been set. The products are still available on the wholesale market.
"The OTC business loses total in the group in importance," said Witt. The group wanted to focus more on the research area. Overall, Astellas has approximately 400 employees, of which 220 sell the products in doctors' offices and clinics.
Legal advisor to Astellas:
The company had emerged from the fusion of the Japanese manufacturers Yamanouchi Seiyaku and Fujisawa YAKUHIN K‐gy‐ 2005. The OTC daughter blade had been taken over by Fujisawa. The two owners are said to have close friends. LM
This announcement appears as a matter of record only Funke Mediengruppe
acquires several best-selling magazine titles from Axel Springer
Legal advisers to Funke Mediengruppe:
Axel Springer sells several of its best-selling magazine titles to Funke media group
FUNKE MEDIENGRUPPE has reached an agreement with Axel Springer AG to acquire Axel Springer AG’s regional newspapers as well as its TV program guides and women’s magazines. In this regard, Axel Springer and FUNKE MEDIENGRUPPE have further agreed to establish joint ventures for the marketing (headed by Peter Würtenberger) and distribution of print and digital media and so to merge their activities, their resources and their know-how in these areas. In both joint venture companies, Axel Springer will have the entrepreneurial leadership and a majority interest. Today, Axel Springer and FUNKE MEDIENGRUPPE have entered into a respective binding preliminary agreement in this respect. The envisaged transaction is planned to be implemented with economic effect as of 1 January 2014. In the fiscal year 2012, the regional newspaper groups as well as the TV program guides and women’s magazines contributed EUR 94.8 million to the EBITDA of Axel Springer Group and EUR 512.4 million to its revenues. The purchase price amounts to EUR 920 million.
Legal advisers to Axel Springer:
In the future, the regional newspapers BERLINER MORGENPOST and HAMBURGER ABENDBLATT, the advertising papers in Berlin and Hamburg as well as the TV program guides and two women’s magazines of Axel Springer (HÖRZU, TV DIGITAL, , BILD der FRAU, FRAU von HEUTE) and the related digital brands will be published by FUNKE MEDIENGRUPPE and will complement its existing portfolio of regional newspapers, advertising papers and magazines.
Jonas This announcement appears as a matter of record only
www.lawyer-monthly.com
Nesselhauf Rechtsanwalte comments: “We confirm our involvement in the transaction. We have advised FUNKE Mediengruppe GmbH & Co. KG, the acquirer, in all aspects relating IP, Copyrights and media matters within the transaction. The transaction was lead with regard to IP by Dr. Volker Knies (partner) with assistance of Sebastian Carl Schmidt (associate), with regard to Copyrights by Dr. Stephanie Vendt (partner) with assistance of Sebastian Carl Schmidt and with regard to media matters by Michael Nesselhauf (partner) and Dr. Stephanie Vendt.” LM
Axel Springer
Astellas
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100